Neoadjuvant durvalumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC)

被引：0
|
作者：
He, J. [1 ]
Zhao, L. [1 ]
Li, L. [1 ]
机构：
[1] PUMCH Peking Union Med Coll Hosp, Thorac Surg, Beijing Xiehe Hosp, Dongdan Campus, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.782
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
203P
引用
收藏
页码：S1553 / S1553
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant pembrolizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim results.
    Wang, Weiwei
    Li, Li
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16011 - E16011
  • [2] Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Lv, Huilai
    Tian, Yang
    Li, Jiachen
    Huang, Chao
    Sun, Bokang
    Gai, Chunyue
    Li, Zhenhua
    Tian, Ziqiang
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Neoadjuvant tislelizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis of a phase 2 study
    Zhuo, Na
    Qiu, Wei
    He, Jia
    Li, Li
    Wang, Qiang
    Yu, Shuangni
    Liu, Wei
    Zhao, Lin
    Bai, Chunmei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma
    Patel, Shetal A.
    Gibson, Michael K.
    Deal, Allison
    Sheth, Siddharth
    Heiling, Hilary
    Johnson, Steven M.
    Douglas, Kathe
    Flores, Melissa
    Blumberg, Jeffrey
    Lumley, Catherine
    Yarbrough, Wendell G.
    Shen, Colette
    Chera, Bhishamjit S.
    Bauman, Jessica R.
    Hackman, Trevor
    Weiss, Jared
    [J]. CANCER, 2023, 129 (21) : 3381 - 3389
  • [5] Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, phase 2 study
    Liu, Jun
    Li, Jingpei
    Lin, Wanli
    Shao, Di
    Depypere, Lieven
    Zhang, Zhifeng
    Li, Zhuoyi
    Cui, Fei
    Du, Zesen
    Zeng, Yuan
    Jiang, Shunjun
    He, Ping
    Gu, Xia
    Chen, Huai
    Zhang, Hai
    Lin, Xiaowei
    Huang, Haoda
    Lv, Wenqiang
    Cai, Weiming
    Liang, Wenhua
    Liang, Hengrui
    Jiang, Wenxi
    Wang, Wei
    Xu, Ke
    Cai, Weipeng
    Wu, Kui
    Lerut, Toni
    Fu, Junhui
    He, Jianxing
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (01) : 128 - 137
  • [6] Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma
    Yang, Guozhen
    Yue, Haodong
    Zhang, Xiaomin
    Zeng, Chufeng
    Tan, Linyu
    Zhang, Xu
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [7] A study of neoadjuvant sintilimab combined with chemotherapy TP for locally advanced esophageal squamous cell carcinoma (ESCC).
    Li, Zhao
    Xu, Peng-Fei
    Mao, Wei-Min
    Kuang, YuKang
    Fan, Hai-Yin
    Zou, Bin
    Zhu, Jian-Feng
    Li, Chao
    Cheng, Xiao-Liang
    Liu, Xing-Fei
    Guo, Changying
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16038 - E16038
  • [8] Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma
    Wu, Zhigang
    Zheng, Qiang
    Chen, Haiquan
    Xiang, Jiaqing
    Hu, Hong
    Li, Hang
    Pan, Yunjian
    Peng, Yizhou
    Yao, Xingxin
    Liu, Pengcheng
    Sun, Yihua
    Li, Bin
    Zhang, Yawei
    [J]. JOURNAL OF THORACIC DISEASE, 2021, 13 (06) : 3518 - 3528
  • [9] Neoadjuvant camrelizumab plus docetaxel and carboplatin in locally advanced esophageal squamous cell carcinoma (ESCC): A prospective study
    Wang, R.
    Zhang, G.
    Zhu, Q.
    Ma, T.
    Weng, C.
    Zhang, D.
    Zeng, H.
    Wang, T.
    Gao, F.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1113 - S1113
  • [10] Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
    He, Wenwu
    Leng, Xuefeng
    Mao, Tianqin
    Luo, Xi
    Zhou, Lingxiao
    Yan, Jiaxin
    Peng, Lin
    Fang, Qiang
    Liu, Guangyuan
    Wei, Xing
    Wang, Kangning
    Wang, Chenghao
    Zhang, Sha
    Zhang, Xudong
    Shen, Xudong
    Huang, Depei
    Yi, Huan
    Bei, Ting
    She, Xueke
    Xiao, Wenguang
    Han, Yongtao
    [J]. ONCOLOGIST, 2022, 27 (01): : E18 - E28
12345